scholarly article | Q13442814 |
P356 | DOI | 10.1128/JCM.00529-16 |
P8608 | Fatcat ID | release_iussaidmfbcbne6nsyca4warmi |
P932 | PMC publication ID | 4922075 |
P698 | PubMed publication ID | 27076663 |
P50 | author | Andrew J Vallely | Q37607022 |
Rebecca Guy | Q58324757 | ||
Steven G Badman | Q58324761 | ||
P2093 | author name string | J M Kaldor | |
J Allan | |||
C Ryan | |||
S N Tabrizi | |||
H Wand | |||
A Kelly-Hanku | |||
A J Vallely | |||
P Siba | |||
S Silim | |||
J Gabuzzi | |||
B Kombuk | |||
A Kumbia | |||
G D L Mola | |||
G Munnull | |||
L Forereme | |||
L M Vallely | |||
P Toliman | |||
Z Kombati | |||
P2860 | cites work | The Measurement of Observer Agreement for Categorical Data | Q26778373 |
WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention | Q27015581 | ||
Global cancer statistics, 2012 | Q27860501 | ||
Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population | Q30301116 | ||
Clinical evaluation of the cartridge-based GeneXpert human papillomavirus assay in women referred for colposcopy | Q30412457 | ||
Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. | Q33923869 | ||
HPV screening for cervical cancer in rural India | Q34973414 | ||
Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis | Q37026425 | ||
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study | Q37135912 | ||
Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis | Q38179114 | ||
Achieving control of cervical cancer in Papua New Guinea: what are the research and program priorities? | Q44346105 | ||
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial | Q61626075 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | human papillomavirus infection | Q184627 |
P304 | page(s) | 1734-1737 | |
P577 | publication date | 2016-04-13 | |
P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
P1476 | title | Field Evaluation of Xpert HPV Point-of-Care Test for Detection of Human Papillomavirus Infection by Use of Self-Collected Vaginal and Clinician-Collected Cervical Specimens | |
P478 | volume | 54 |
Q95499867 | Q95499867 |
Q55241245 | A prospective pilot evaluation of vaginal and urine self-sampling for the Roche cobas 4800 HPV test for cervical cancer screening. |
Q64097137 | Barriers to cervical cancer screening among rural women in eastern China: a qualitative study |
Q92506705 | Cancer control in small island nations: from local challenges to global action |
Q92506711 | Cancer control in the Pacific: big challenges facing small island states |
Q92506700 | Cancer management in the Pacific region: a report on innovation and good practice |
Q64264624 | Developing a culturally appropriate illustrated tool for the self-collection of anorectal specimens for the testing of sexually transmitted infections: lessons from Papua New Guinea |
Q45074054 | Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study. |
Q64274461 | Health service delivery models for scaling use of point-of-care HPV 'test and treat' strategies in high-burden, low-income settings |
Q40370700 | High prevalence of HPV infection in the remote villages of French Guiana: an epidemiological study |
Q89471393 | Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol |
Q91629051 | Is It Relevant to Keep Advocating Visual Inspection of the Cervix With Acetic Acid for Primary Cervical Cancer Screening in Limited-Resource Settings? |
Q58587240 | Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the cervix with acetic acid, for the detection of underlying high-grade squamous intraepithelial le |
Q48330261 | Performance of syndromic management for the detection and treatment of genital Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis among women attending antenatal, well woman and sexual health clinics in Papua New Guinea: a cross- |
Q90313337 | Performance of vaginal self-sampling for human papillomavirus testing among women living with HIV in Botswana |
Q28075858 | Point-of-Care Diagnostics for Improving Maternal Health in South Africa |
Q47549030 | Predictors of abnormal cytology among HPV-infected women in remote territories of French Guiana |
Q58800228 | Protocol for the study of cervical cancer screening technologies in HIV-infected women living in Rwanda |
Q37709706 | Recent advances in understanding and preventing human papillomavirus-related disease |
Q54229599 | Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs. |
Q47129496 | The Role of Affordable, Point-of-Care Technologies for Cancer Care in Low- and Middle-Income Countries: A Review and Commentary |
Q38372381 | The time is now to implement HPV testing for primary screening in low resource settings |